Kathila Rajapaksa - Senior Scientist, Safety Assessment

Kathila Rajapaksa

Senior Scientist, Safety Assessment

"Genentech’s fosters cutting-edge science and encourages innovation. It has been a great privilege to be part of this culture."
5
Years at Genentech
1
Publications
4
Awards & Honors

I joined Genentech in 2012 as a project toxicologist having worked in the Biotech industry for 5 years. When I arrived I was most impressed with Genentech’s culture that fosters cutting-edge science and encourages innovation. Additionally as scientist we are allowed a great deal of freedom here and it has been an honor to be part of this.

As a project toxicologist on cross functional teams, I provide scientific leadership, evaluate safety liabilities, proactively manage safety liabilities by designing strategies and studies, provide input on issues arising during manufacturing process, and support regulatory filings.

Featured Publication

Preclinical Safety Profile of a Depleting Antibody against CRTh2 for Asthma: Well Tolerated Despite Unexpected CRTh2 Expression on Vascular Pericytes in the Central Nervous System and Gastric Mucosa.

Toxicol Sci. 2016 Jul;152(1):72-84.

Rajapaksa KS, Huang T, Sharma N, Liu S, Solon M, Reyes A, Paul S, Yee A, Tao J, Chalasani S, Bien-Ly N, Barck K, Carano RA, Wang J, Rangell L, Bremer M, Danilenko DM, Katavolos P, Hotzel I, Reif K, Austin CD.